Top News Stories

Measles Exposure at Shakira’s MetLife Concert: In May 2025, New Jersey health officials warned that concertgoers at Shakira’s sold-out performance at MetLife Stadium may have been exposed to measles. This exposure presents significant concerns regarding public health safety, disease transmission, and the legal implications of communicable diseases at large public events. Measles, a highly contagious viral infection, can cause serious complications, especially among unvaccinated individuals. This incident also highlights the intersection of personal health responsibility, public health policy, and legal frameworks surrounding communicable diseases in the United States.

By early 2025, former President Donald Trump’s proposed Tax Blueprint legislation had crystallized into the centerpiece of his economic agenda—and the linchpin of intra-party contention. The Wall Street Journal aptly described the unfolding drama: “Trump’s Economic Agenda Hinges on Tax Bill That Divides His Party.” At its core, the proposal would cut the top marginal individual rate from 37 percent to 28 percent and reinstate full expensing for capital investment, offset by scaling back popular deductions for state and local taxes and eliminating the alternative minimum tax (AMT) (Wall Street Journal, 2025). Yet while ardent conservatives cheered reductions that they believe would spur growth, other Republican fiscal hawks and moderates balked at the package’s projected $2 trillion deficit impact over ten years.

On May 15, 2025, the U.S. Food and Drug Administration (FDA) approved the first-ever Oral Alzheimer's Drug, marking a significant milestone in both medical and regulatory history. The approval of this groundbreaking drug raises questions not only about the future of Alzheimer’s treatment but also about the legal and regulatory processes involved in the approval of new pharmaceuticals, especially in the context of highly politicized health issues. This article will explore the various aspects of this approval, focusing on the legal framework, potential policy ramifications, and public debates surrounding the drug’s approval. At the core of the discussion is the tension between rapid innovation in healthcare and the regulatory mechanisms that ensure drug safety and efficacy.

In recent weeks, Puerto Rico has been rattled by a series of seismic events, which have raised significant concerns about the safety of the island's infrastructure. The persistent earthquake swarm has exposed weaknesses in the structural integrity of key facilities and raised questions about the adequacy of existing safety protocols. These concerns are not only a matter of public safety but also highlight the legal and policy implications that accompany such natural disasters. As Puerto Rico remains under the sovereignty of the United States, the response to these events is compounded by complex legal frameworks that govern emergency management, federal funding, and infrastructure development.